|
Shanghai Agrotree Chemical Co., Ltd
|
Characters: A white or almost white powder, freely soluble in water, practically insoluble in alcohol and ether.
Specific optical: +117°
Identification Tests: Complies according to the monograph
pH: 4.9
Appearance of solution: Clear and not more intensely colored than degree 6 of the range of reference solution of the most appropriate color.
Composition: C1: 25.9%, C1a: 22.7%, C2+C2a: 51.4%
Sulphate: 34.4%
Water: 8.4%
Sulphate ash: 0.2%
Methanol: Not more than 1.0 percent
Bacterial endotoxins: Less than l .67IU/mg
Determination of content: Anhydrous substance = 633O/mg, Hydrous substance = 580O/mg
Conclusion: Complies with the standard of BP/EP |
Send Inquiry
|
|
Shanghai Agrotree Chemical Co., Ltd
|
|
TEST
|
RESULTS
|
|
Characters
|
|
A white powder, freely soluble in water, practically insoluble in alcohol and ether
|
|
| |
Identification
|
|
Conform to the requirement
|
|
| |
Appearance of solution
|
|
Conform to the requirement
|
|
| |
Acidity(pH)
|
|
5.4
|
|
| |
Specific Optical Rotation
|
|
+120°
|
|
| |
Methanol
|
|
Confbnn to the requirement
|
|
| |
Composition
|
|
25.5%
|
|
| |
29.1%
|
|
| |
45.4%
|
|
| |
Water
|
|
9.9%
|
|
| |
Sulfated Ash
|
|
0.3%
|
|
| |
Sulfate
|
|
32.5%
|
|
| |
Bacterial endotoxins
|
|
Not more than 1.67 lU/mg
|
|
| |
Assay
|
|
646 lU/mg
|
|
| |
582 lU/mg
|
|
|
Send Inquiry
|
|
TAIZHOU SUNZONE PHARMACEUTICAL LTD
|
Product name: Gentamycin Sulfate Injection 80mg/2ml
Package: 2ml x 10 Ampoules
Shelf-life: 36 months
Indications:
Gentamycin Sulfate Injection is a broad - spectrum antibacterial drug of the aminoglycoside class. It is used to treat severe infections caused by sensitive Gram - negative bacilli, such as Escherichia coli, Klebsiella, Enterobacter, Proteus, Serratia, Pseudomonas aeruginosa, and methicillin - sensitive strains of Staphylococcus, including septicemia, lower - respiratory - tract infections, intestinal infections, pelvic infections, abdominal infections, skin and soft - tissue infections, and complicated urinary - tract infections. |
Send Inquiry
|
Pharma Sources Insight January 2025
